Beta Bionics, Inc.
BBNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $30 | $27 | $28 |
| Short-Term Investments | $73 | $70 | $0 |
| Receivables | $12 | $4 | $0 |
| Inventory | $13 | $1 | $0 |
| Other Curr. Assets | $4 | $1 | $1 |
| Total Curr. Assets | $133 | $104 | $28 |
| Property Plant & Equip (Net) | $11 | $6 | $7 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $5 | $0 | $0 |
| Total NC Assets | $17 | $6 | $7 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $150 | $110 | $36 |
| Liabilities | – | – | – |
| Payables | $3 | $1 | $0 |
| Short-Term Debt | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $0 |
| Other Curr. Liab. | $16 | $8 | $7 |
| Total Curr. Liab. | $21 | $11 | $9 |
| LT Debt | $6 | $3 | $3 |
| Deferred Rev, NC | $2 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $45 | $38 | $10 |
| Total NC Liab. | $52 | $41 | $14 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $7 | $4 | $4 |
| Total Liabilities | $74 | $51 | $23 |
| Equity | – | – | – |
| Pref Stock | $321 | $262 | $183 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$297 | -$230 | -$186 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $51 | $26 | $16 |
| Total Equity | $76 | $59 | $13 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $150 | $110 | $36 |
| Net Debt | -$23 | -$22 | -$24 |